Price T Rowe Associates Inc Statera Biopharma, Inc. Transaction History

Price T Rowe Associates Inc

  • $816 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.21 - $0.38 $10,395 - $18,810
49,500 Added 423.08%
61,200 $17,000
Q1 2022

May 16, 2022
BUY
$0.31 - $2.27 $3,627 - $26,559
11,700 New
11,700 $4,000

Others Institutions Holding STAB

# of Institutions
4
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Statera Biopharma, Inc.

STAB Quotes by TradingView
  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email